Chiropractors in Gurabo, PR Accepting Medicare

4 Chiropractors found. Showing 1 - 4

Lifestyle Chiropractic Chiropractor Medicare: Not Enrolled in Medicare Practice Location: Sabanera Del Rio, #395 Camino Trinitarias, Gurabo, PR 00778 Phone: 787-319-5176

Alexys Colon, DC Chiropractor Medicare: Not Enrolled in Medicare Practice Location: Villa Alegre E-4, Calle 6, Gurabo, PR 00778 Phone: 939-239-0598

Inerva, Llc Chiropractor Medicare: Medicare Enrolled Practice Location: Plaza Marina Suite #13, 535 Carr. 189 Km. 6.40, Gurabo, PR 00778 Phone: 787-414-9898    Fax: 787-561-7464

Antonio Rodriguez Perez, D.C. Chiropractor Medicare: Medicare Enrolled Practice Location: Plaza Marina Suite #13, 535 Carr. 189 Km. 6.40, Gurabo, PR 00778 Phone: 787-414-9898    Fax: 787-561-7464

News Archive

GI Dynamics announces positive results from EndoBarrier studies against type 2 diabetes

GI Dynamics, a leader in non-surgical, endoscopic treatments for type 2 diabetes and obesity, announced today new results from three studies that demonstrate the positive effects of the EndoBarrier Gastrointestinal Liner on type 2 diabetes, weight loss and other metabolic factors.

NIH awards grant totaling $19.5M for Down syndrome research project

Scientists and data experts are joining forces to create the world's first centralized platform for Down syndrome researchers to share, access, and analyze data.

Viewpoints: Censoring flu research; Assailing Komen's move to cut Planned Parenthood funding

In December, the National Science Advisory Board for Biosecurity made an unprecedented request: it asked the editors of the journals Nature and Science not to publish certain details in two papers describing experiments in which scientists created a highly transmissible form of the deadly H5N1 influenza virus. ... Such caution, though well intentioned, is misplaced.

FDA issues letter directing GSK to revise product labeling for Serevent and Advair

GlaxoSmithKline today announced that it has received a letter from the U.S. Food and Drug Administration directing revisions to product labeling for its respiratory products Serevent and Advair. The letter concludes discussions between GSK and the agency following FDA advisory committee meetings regarding the safety profile of long-acting beta2-agonists in the treatment of asthma, including salmeterol, the active ingredient in Serevent and one of the active ingredients in Advair.

Study could improve patients' abilities to manage symptoms of mental illness

Approximately 1 in 5 adults in the United States experience mental illness in a given year. Severe mental illnesses cause the brain to have trouble dealing with cognitively effortful states, like focusing attention over long periods of time, discriminating between two things that are difficult to tell apart, and responding quickly to information that is coming in fast.

Read more Medical News

› Verified 9 days ago